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Background. Viral load (VL) quantification is an important tool in determining newly developed drug resistance or problems with adherence 
to antiretroviral therapy (ART) in HIV-positive patients. VL monitoring is becoming the standard of care in many resource-limited settings. 
Testing in resource-limited settings may require sampling by fingerstick because of general shortages of skilled phlebotomists and the 
expense of venepuncture supplies and problems with their distribution.
Objective. To assess the feasibility and ease of collecting 150 µL capillary blood needed for the use of a novel collection device following a 
classic fingerstick puncture.
Methods. Patients were recruited by the study nurse upon arrival for routine ART monitoring at the Themba Lethu Clinic in 
Johannesburg, South Africa. Each step of the fingerstick and blood collection protocol was observed, and their completion or omission 
was recorded.
Results. One hundred and three patients consented to the study, of whom three were excluded owing to the presence of callouses. From a 
total of 100 patients who consented and were enrolled, 98% of collection attempts were successful and 86% of participants required only 
one fingerstick to successfully collect 150 µL capillary blood. Study nurse adherence to the fingerstick protocol revealed omissions in several 
steps that may lower the success rate of capillary blood collection and reduce the performance of a subsequent VL assay.
Conclusion. The findings of this study support the feasibility of collecting 150 µL of capillary blood via fingerstick for point-of-care HIV-1 
VL testing in a resource-limited setting.
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The World Health Organization (WHO) has esti-
mated that about 34 million individuals are infected 
by the current HIV/AIDS pan demic.[1] Although 
much progress has been made in controlling this 
disease, in sub-Saharan Africa approximately 23 
million people remain infected,[1] with South Africa (SA) alone 
contributing about 11 087 cases/100 000 population.[1]
The monitoring of the HIV viral load (VL) in patients receiving 
antiretroviral therapy (ART) is critical to ensure treatment success, 
identify problems with treatment adherence, and identify HIV drug 
resistance to inform the decision to switch to second-line or future 
third-line therapies.[2] Currently there is much discussion regarding 
the role of VL monitoring in the care of HIV/AIDS patients. The 
WHO recommends VL monitoring as the preferred approach because 
of its ability to identify treatment failure earlier than immunological 
and clinical modalities.[2] Treatment failure is defined by the WHO as 
a plasma VL >1 000 copies/mL after two consecutive measurements 
during a 3-month interval accompanied by adherence support.[2] 
However, despite the updated WHO recommendations, poor access 
to VL testing often persists in resource-limited settings owing to 
simple logistical issues such as the collection and transportation of 
specimens.
Recently, alternatives such as dried blood spots (DBSs) and point-
of-care (POC) devices are being investigated as potential ways to 
increase access to VL testing in low- and middle-income countries 
(LMICs). While standard laboratory platforms typically retain high 
accuracy when utilising the recommended threshold of 1 000 copies/
mL, both DBS and POC devices may need to utilise a higher limit 
(3 000 - 5 000 copies/mL has been suggested) until better sensitivity 
is established at the lower limit of detection.[2] A study by Viljoen 
et al.[3] in Durban using DBS HIV-1 RNA testing appeared accurate 
and feasible down to approximately 3 000 copies/mL. In a study 
conducted in southern India by Neogi et al.,[4] DBS HIV-1 RNA 
testing revealed 100% sensitivity and specificity at 5 000 copies/mL, 
but only 50% sensitivity with 100% specificity at 1 000 copies/mL. 
Most recently, when Kleshik et al.[5] quantified HIV-1 RNA in single 
50 µL DBSs and limited incubation time prior to sample preparation 
to 30 minutes, a limit of detection of 866 copies/mL was reported.
An important concern regarding the use of DBSs for HIV-1 RNA 
quantification is the amplification of cell-associated HIV nucleic 
acid in whole blood, leading to a falsely high VL measurement 
when compared with the amplification of viral nucleic acid in 
plasma specimens. Several recent studies using DBSs have shown 
reasonable correlation for VLs >3 000 copies/mL, but significant over-
quantification has been observed in specimens with <3 000 copies/
mL.[6-9] Unless this over-quantification is addressed, the usefulness 
of DBSs for VL monitoring may be limited in samples containing 
<3 000 copies/mL.
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DBSs may serve to improve access to VL 
monitoring by linking any existing central 
laboratory infrastructure to regions with 
poor access to VL testing, where transport 
delays and centrifugation to plasma are 
not feasible. However, blood collection and 
the shipment of DBSs, with subsequent VL 
quantification and reporting of results, is not 
easily achieved during the same day in order 
to impact on patient care on the same visit. 
Rapid POC testing may address this logistical 
shortcoming by quantifying VL on site during 
the same visit. Subsequent ART intervention 
may then take place during the same day, as 
patients with poor adherence to treatment or 
those with newly developed drug resistance 
are screened earlier in the process.
Shortages of skilled phlebotomists and 
the expense of venepuncture supplies have 
contributed to the development of a POC VL 
quantification device for use in resource-limited 
settings that may utilise sampling by fingerstick 
instead of venepuncture. Fingerstick specimens 
are currently used for a wide range of tests 
for haematology, chemistry and serology.[10-13] 
Recently the University of the Witwatersrand, 
Johannesburg, SA, investigated the feasibility 
and accuracy of performing multiple point-
of-care tests (POCTs) on fingersticks. This 
study found that capillary blood for up to 
four POCTs (95 µL) could be obtained from 
a single fingerstick in 92% of the subjects.[14] 
A collaboration between the Quidel Corpor-
ation and the Northwestern Global Health 
Foundation (NWGHF), USA, is deve loping a 
POC RT-PCR testing platform and VL assay 
that will require a volume of 150 µL capillary 
blood to reach a sensitivity with a lower limit 
of detection of 1 000 copies/mL.[12] The 150 µL 
whole blood will be converted to plasma 
using sample preparation materials provided 
by the NWGHF.[12] A significant barrier to 
implementing this platform in the future will 
be overcome if 150 µL capillary blood can be 
reliably collected following a fingerstick. In 
order to facilitate the collection of capillary 
blood for this study, a novel EDTA-treated 
capillary blood collection device with a capacity 
of 150 µL was developed.
The aim of this study was to assess: (i) 
the proportion of collection attempts that 
obtain 150 µL capillary blood using a newly 
developed fingerstick-based collection 
device; (ii) the number of puncture sites 
required to obtain 150 µL blood; and (iii) 




The study was conducted at the Themba 
Lethu Clinic at Helen Joseph Hospital, 
Johannesburg, where a medical student from 
the Feinberg School of Medicine in Chicago, 
USA, observed a study nurse perform 
fingerstick punctures and collect capillary 
blood specimens from 100 patients having 
routine blood tests for ART monitoring. Each 
patient routinely received one venepuncture 
for blood collection during their visit. 
Fingerstick punctures were not performed at 
this clinic for the routine blood tests involved 
in ART monitoring. For the purposes of 
this study, a phlebotomist first performed a 
venepuncture on each patient for their routine 
blood tests and then one or more fingersticks 
were performed by the study nurse. The study 
nurse was highly experienced, with over 
1 000 venepunctures and 1 000 fingersticks 
performed during her career.
Eligible patients were HIV-positive indi-
viduals currently receiving ART who had 
previously been tested for CD4 and/or HIV 
VL. Primary exclusion criteria included 
the presence of heavy callouses, severe 
dehydration, clinically identifiable illness and/
or opportunistic infection, and persistently 
cold fingers after a warming attempt. Suitable 
participants were recruited from the blood 
collection room after a phlebotomist had 
administered venepuncture and collected 
the requested routine standard-of-care blood 
specimens. Each patient was asked to sign an 
informed consent waiver before enrolling in 
the study and receiving a fingerstick. Ethics 
approval for this study was granted by the 
Institutional Review Board at Northwestern 
University (ID: STU00076689) and the 
Human Research Ethics Committee at the 
University of the Witwatersrand (Protocol 
M120143).
Data collection and measurements
Fingerstick punctures were delivered using 
a device with a blade depth and width of 
2.0 mm and 1.5 mm, respectively. The 
BD Microtainer Contact-Activated Lancet 
(BD Diagnostics, USA) was initially used 
to deliver fingerstick punctures until 
a stock shortage necessitated the use of 
the BD Genie Lancet (BD Diagnostics), 
with identical blade depth and width 
specifications. The study nurse was not 
given explicit instructions on how to 
perform the fingersticks; instead, she was 
simply asked to perform them according 
to her usual methods until blood collection 
was complete. A fingerstick and blood 
collection protocol checklist was created for 
the purpose of this study to assess baseline 
study nurse adherence to the protocol 
without training or specific instructions 
provided. The study nurse was blinded 
with respect to the fingerstick and blood 
collection protocol checklist used to assess 
adherence (Appendix 1) for the fingerstick 
and blood collection protocol in its entirety.
A novel blood collection device capable 
of holding 150 µL was used to discriminate 
between successful and unsuccessful col-
lection attempts. The device contained sev-
eral layers of EDTA-treated membrane strips 
designed to wick exactly 150 µL capillary 
blood. A complete collection was described 
to the nurse as the moment when both the 
front and rear of the membrane strips in 
the collection device appeared solid red in 
colour. Each step of the protocol checklist 
was observed, and completion or omission of 
any step was recorded on a template for every 
patient. A stopwatch was started immediately 
after the fingerstick to time the duration of 
the fingerstick procedure followed by blood 
collection. When more than one fingerstick 
was necessary, the study nurse obtained ver-
bal consent before proceeding with each 
additional fingerstick. The result of each 
collection attempt was recorded. The study 
nurse performed translations as needed. Any 
unique insights offered by her were docu-
mented.
Results
A total of 132 patients were approached 
for participation in this study. Twenty-nine 
patients refused to give consent: 18 offered 
no reason for their refusal to do so, 7 stated 
that they were in a hurry, 2 did not want 
additional tests performed, and 2 stated that 
they were scared of receiving a fingerstick. Of 
the remaining 103 patients, 3 were excluded 
from the study because of the presence of 
callouses and/or extremely thick skin, self-
described as relating to their respective 
occupations. One hundred remaining 
patients participated in the study.
Ninety-eight out of 100 collection attempts 
were successful, and 86% required only 
one fingerstick to successfully collect 150 
µL of capillary blood (Table 1). The two 
failed collection attempts were in adult men 
without callouses, exceptionally thick skin 
Table 1. Number of fingersticks required 









*One collection attempt failed to obtain 150 µl blood.
†The combined collection from four fingersticks failed to 
produce 150 µL blood.
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or persistently cold fingers after a warming attempt. After four 
consecutive fingersticks were conducted on the first patient, he 
refused additional attempts. In the second patient, slow blood flow 
was observed after the first fingerstick. He declined to give consent 
to perform any additional fingersticks. Neither patient exhibited a 
negative response to receiving their fingerstick(s), as neither was 
observed to wince in pain, pull away or cry out. Neither patient 
exhibited physical signs of dehydration, but further questioning 
revealed a history of possible low fluid intake.
The mean time to perform one fingerstick followed by a successful 
collection was 76 seconds (range 27 - 225). Study nurse adherence to 
the fingerstick and blood collection protocol is summarised in Table 2.
Discussion
The successful monitoring of VL in patients receiving ART is critical 
in identifying treatment failure resulting from adherence issues 
or the development of HIV drug resistance. The world’s largest 
population of HIV-positive individuals resides in sub-Saharan Africa, 
yet this region has variable and often limited access to VL testing. 
Development of a simple, cost-effective and readily accessible VL 
assay with high sensitivity is therefore needed. Currently, DBSs 
and novel POC platforms are being investigated as opportunities 
to expand access to VL monitoring in LMICs. Failure to access VL 
testing is frequently due to simple issues such as sample collection 
and transport. This study aimed to assess the feasibility of collecting 
150 µL of capillary blood following a fingerstick puncture for use in a 
POC rapid RT-PCR testing platform and VL assay.
Although 86% of collection attempts successfully achieved a 
complete collection from a single fingerstick, the study nurse 
adherence to the protocol (Table 2) revealed omissions in several 
key steps that may adversely affect the success of capillary blood 
collection and/or the sensitivity of a subsequent VL assay. However, 
it should be noted that fingerstick device training may occur in an 
informal manner that fails to emphasise strict adherence to every 
step of the detailed manufacturer’s protocol for fingerstick blood 
collection. Notably, with 0% adherence, the study nurse was never 
observed wearing a pair of gloves during this study. While wearing 
gloves ultimately has no effect on the success of blood collection, 
repeated omission of this step may inform the subsequent design 
of a blood collection device that minimises the risk of healthcare 
worker contact with the collected blood specimen.
The two most commonly omitted steps that may adversely affect 
the success of blood collection were: (i) patient’s fingers warmed 
in advance by any method; and (ii) positioning of the patient’s 
hand below elbow level, with 7% and 56% adherence, respectively 
(Table 2). Occasionally a patient with cold fingers was asked to rub 
their hands together quickly to generate heat. A warm cloth, which 
would have been ideal, was not readily available for the purpose 
of warming fingers. Placement of the patient’s hand below the 
level of their elbow also presented a significant challenge in many 
cases. Patients were seated in a chair rather than on an elevated 
examination table because they were subjected to phlebotomy 
immediately before fingerstick testing, and the routine practice in 
this setting was for phlebotomy to be done with the patient in a 
chair. Placing the patient’s hand below the level of their elbow while 
seated in a chair meant that the study nurse would have to bend over 
and painstakingly reach down in order to perform the fingerstick 
and observe progress in filling the collection device. Lastly, the first 
drop of blood was wiped away from the puncture site in only 5% of 
all fingersticks performed in this study (Table 2). It is hypothesised 
that the first drop of blood may contain interstitial fluid that could 
adversely affect the results of a subsequent VL assay, but this has yet 
to be confirmed.
Omissions in potentially important steps of the protocol suggest 
that when a POC VL platform and novel VL assay are first introduced 
to clinics, supplemental quick reference materials and/or brief 
maintenance training may improve the quantitative performance of 
a POC VL assay. When training healthcare personnel or preparing a 
protocol checklist for them in the future, special attention should be 
given to those frequently omitted steps that may adversely affect the 
outcome of a subsequent assay. The need for ongoing quality monitoring 
and training has been reported for performing rapid HIV testing and 
is a critical component of successful diagnostics.[15] Additionally, 
all necessary fingerstick materials should be conveniently located 
to facilitate optimal adherence to the manufacturer’s fingerstick 
protocol.
The unique perspective of the study nurse highlighted several 
important benefits of performing a fingerstick over venepuncture. 
First, nurses or community healthcare workers with minimal 
training can perform fingersticks, potentially resulting in increased 
access to VL monitoring for patients. Nursing assistants in SA, for 
instance, receive 1 year of formal training and are not qualified to 
perform venepuncture on patients. A POC VL quantification assay 
relying on fingersticks rather than venepuncture could be widely 
utilised by this workforce. Second, fingersticks result in fewer blood 
spills and so decrease biohazard risk to healthcare workers, and 
require far less blood than venepuncture. In some cases a dehydrated 
and/or sick patient will provide an insufficient quantity of blood 
by venepuncture, requiring the test(s) to be completed again at a 
later time. Fingerstick blood collection may be more successful 
than venepuncture in certain patients. Finally, fingersticks require 
less counter space, fewer waste bins and less disposal of packaging 
materials.
The transition to fingerstick blood collection for VL testing 
may initially complicate the workflow in clinics that require 
other routine tests for ART monitoring. Venepuncture blood 
collection is often used for a variety of laboratory tests, including 
but not limited to CD4, a full blood count, liver function 
tests, and haemoglobin, creatinine, cholesterol and triglyceride 
measurements. A transition to fingerstick blood collection for VL 
testing would initially require phlebotomists to perform one or 
more fingersticks in addition to venepuncture for most patients. 
The overall utility of fingerstick blood collection would therefore 
increase if multiple POC tests could be performed simultaneously 
for ART monitoring.
Table 2. Nurse adherence to protocol
Protocol steps Adherence, % (N)
Pair of gloves worn by nurse 0 (0)
Patient sitting 100 (100)
Patient’s fingers warmed in advance 7 (7)
Puncture site disinfected with alcohol pad 86 (101)
First drop of blood wiped away 5 (109)
Hand positioned palm down 100 (100)
Hand positioned below elbow 56 (65)
Collection device held above skin; scraping 
avoided
96 (104)
Gentle pressure applied; strong milking 
avoided
95 (103)
Pressure applied after collection 100 (100)
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Conclusions
Capillary blood collection was highly successful in this study, with the 
vast majority of patient encounters yielding 150 µL blood after only 
one or two fingersticks. The widespread implementation of a POC 
VL assay in a resource-limited setting would not be hindered by the 
ability to collect the targeted volume of 150 µL capillary blood when 
using the appropriate lancet, but would require training and ongoing 
quality monitoring.
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Fingerstick and blood collection protocol 
1. Assemble materials
• Disposable gloves
• 70% isopropyl alcohol pads
• Lancets
• Blood collection device
• Sterile gauze pad
• Warming device (moist towel or sodium acetate hand warmer)
2. Wash hands and put on pair of disposable gloves
3. Position patient and select the fingerstick puncture site
• Patient should be sitting or lying down
• Patient should have their hand in a downward position, allowing 
gravity to increase blood supply to the hand
• Middle or ring finger is preferable; fifth finger should not be 
punctured, because tissue depth is insufficient to prevent bone injury
4. Warm the site
• Use a warm, moist towel or other appropriate warming device 
(not exceeding 40oC/105oF) for 3 minutes; alternatively, have the 
patient vigorously rub their hands together to generate heat
5. Disinfect the site
• Cleanse the site using a 70% isopropyl alcohol pad
• Allow the site to air dry in order to provide effective disinfection 
and to prevent possible haemolysis or erroneous results from 
residual alcohol
6. Perform the puncture
• Have the patient hold their hand below elbow level
• Turn the patient’s hand palm down
• Hold the lancet with two fingers
• Position the lancet firmly against the puncture site
• Press lancet against puncture site until release mechanism is 
activated
7. Discard used lancet into a sharps container
8. Collect the blood specimen
• Wipe away the first drop of blood, as this drop may contain 
an excess of tissue fluids that may cause erroneous results
• Position the collection device directly beneath the puncture 
site and avoid scraping across skin
• Gently apply intermittent pressure along finger capillaries and 
open the puncture slightly to maximise blood flow
• Avoid strong repetitive pressure or ‘milking’, as this may cause 
haemolysis or tissue fluid contamination of the specimen
• Blood collection is complete when both sides of the collection 
device appear solid red in colour
9. Cover the puncture site and dispose of all materials
• Wipe the site dry and apply direct pressure with a sterile 
gauze pad until bleeding has stopped
• Place all used materials in appropriate biohazard containers
Appendix 1
